384 related articles for article (PubMed ID: 26794314)
1. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
Sohrabi S; Haeri A; Mahboubi A; Mortazavi A; Dadashzadeh S
Int J Biol Macromol; 2016 Apr; 85():625-33. PubMed ID: 26794314
[TBL] [Abstract][Full Text] [Related]
2. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
3. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
10. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Chhibber T; Gondil VS; Sinha VR
AAPS PharmSciTech; 2020 Jan; 21(2):43. PubMed ID: 31897806
[TBL] [Abstract][Full Text] [Related]
11. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
12. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
13. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
[TBL] [Abstract][Full Text] [Related]
14. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
16. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
[TBL] [Abstract][Full Text] [Related]
17. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.
Abdelbary A; Salem HF; Khallaf RA; Ali AM
Pharm Dev Technol; 2017 May; 22(3):409-417. PubMed ID: 27476543
[TBL] [Abstract][Full Text] [Related]
19. Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery.
Jana S; Manna S; Nayak AK; Sen KK; Basu SK
Colloids Surf B Biointerfaces; 2014 Feb; 114():36-44. PubMed ID: 24161504
[TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]